QIAGEN Digital Insights, the bioinformatics arm of QIAGEN, is collaborating with Evotec to create multi-omics data insights for understanding diseases better and creating more precise and effective therapeutic options.
This partnership combines QIAGEN's bioinformatics tools and Evotec's multimodality platform for producing novel therapeutics. The collaborative effort is expected to increase efficiency and lower the costs of analyzing DNA, RNA, and proteins to reveal actionable insights valuable to healthcare, academia, and the pharmaceutical industry. With QIAGEN's database and Evotec's technology, the companies hope to expand their reach and further assist in important areas of medical research such as neurology, oncology, and infectious diseases.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.